HMGB1 and autoimmune polyendocrinopathy: In the present study, we investigated plasma levels of both HMGB1 and sRAGE in pAPS patients, APA-positive SLE patients without APS menifestations (APA+SLE patients) and SLE patients with secondary APS (APS+SLE patients).